TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded without competitionContract award notice
Published 8 Dec 2025, 14:57 GMT

Official UK procurement notice

Contract for Netspot (Gallium Ga 68 Dotatate)

Official notice

Authority: The Royal Marsden NHS Foundation Trust (Central government)·On behalf of: Central London Community Healthcare NHS Trust

Direct awardSME suitableVCSE suitable
Sectors: Medical Devices & Pharma (33) Delivery: London (UKI)
Awarded value£316,800published award · exc. VAT
Award in standstill 8 Dec 2025no call for competition
Award (standstill) to NOVARTIS PHARMACEUTICALS UK LIMITED

What is being bought

Published requirement description

Contract for Netspot Kits required by the trust

The lotProcurement structure

single lot · no lot value published
Lot #1AwardedSMEVCSE
Delivery: LondonEligibility: SME eligibleVCSE eligible
33696500 Laboratory reagents

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
8 Dec 2025, 14:57 GMT
Last source update
8 Dec 2025, 16:45 GMT
FTS notice number
2025/S 000-080795
Latest notice
Contract award notice (UK6)
Delivery area
London (UKI)
Official registry OCID
ocds-h6vhtk-05f0eb Find a Tender
Why no open competition
Single Suppliers Technical Reasons
Published justification

There is currently only one gallium Dotatate kit NetSpot on the market, the other alternative is gallium dotatoc Somakit (licensed) which is not the exact pairing diagnostic to Lutetium Dotatate therapy.

Review and risk notes
Risks

As this is the only dotatate kit available, patient will not get their screening scan to determine if they are eligible for Lutetium dotatate treatment. Delays in treatment, and unable to determine if treatment is effective in the staging scan.

How it was run

Official notice
Submission deadline
—

Timeline

8 Dec 2025 → 17 Dec 2025 · 2 dates
  1. Notice published322 days ago
    8 Dec 2025, 16:45 GMT
  2. Standstill ends313 days ago
    17 Dec 2025, 23:59 GMT

Notice history

3 events · 2 releases on Find a Tender · since 8 Dec 2025
  1. Transparency notice published
    8 Dec 2025, 14:57 GMT
    UK5
  2. Contract award notice published
    8 Dec 2025, 16:45 GMT
    UK6
  3. Contract signature expected
    19 Dec 2025, 23:59 GMT
    scheduled

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £316,8001 award exc. VAT
Awarded toValueDateStatus
NOVARTIS PHARMACEUTICALS UK LIMITED19 Dec 2025 – 31 Oct 2026£316,8008 Dec 2025standstill to 17 Dec 2025Standstill

Contracting authority & participating public bodies

2 public bodies on the notice

The Royal Marsden NHS Foundation Trust

Contracting authorityPublic authority - central government GB-PPON: PXLT-9823-WVCY Fulham Road, London, London, SW3 6JJContact email

Other public bodies

  • Central London Community Healthcare NHS TrustProcuring entityCLCH Hosts North West London Procurement Services that undertake the procurements for multiple trusts including The Royal MarsdenGB-PPON: PJXH-4297-MQQW London, LondonContact email

Bidders & participating suppliers

1 commercial party on the notice
  • Novartis Pharmaceuticals UK LimitedAwarded supplierGB-PPON: PJTX-5182-QVLR 2nd Floor The WestWorks Building White City Place 195 Wood Lane, London, London, W12 7FQContact email

Official documents & specifications (2)

Official links; attachments are not copied

Notices published for this procedure

  • Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender
  • Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender